No. 15 — The Uniform Controlled Substances Act and the Architecture of Modern Drug Scheduling

No. 15 — The Uniform Controlled Substances Act and the Architecture of Modern Drug Scheduling

A Structural Analysis of State Scheduling Mechanisms in a Post-Medical Recognition Era

By Jason Karimi | WeedPress Policy Series No. 15
March 1st, 2026

Note: The following notes were provided from Vicente LLP and are referenced in this article:

I. Introduction: Uniformity as Structural Design

In 1970, Congress enacted the Comprehensive Drug Abuse Prevention and Control Act, including the federal Controlled Substances Act (“CSA”).¹ The statute established five schedules and defined Schedule I substances as those having:

“(A) a high potential for abuse;
(B) no currently accepted medical use in treatment in the United States; and
(C) a lack of accepted safety for use under medical supervision.”²

In the same year, states began adopting their own Controlled Substances Acts, many modeled on the Uniform Controlled Substances Act (“UCSA”).³

The result was national alignment of drug scheduling categories.

But alignment of categories did not produce uniformity of mechanisms.

States diverged in how they structured conformity to federal scheduling changes. Those structural decisions now determine how federal medical recognition interacts with state law.

⸻

II. The Uniform Law Commission and the 1970 Uniform Controlled Substances Act

The Uniform Controlled Substances Act was promulgated in 1970 by the National Conference of Commissioners on Uniform State Laws (now the Uniform Law Commission).⁴ The Act was drafted immediately following federal enactment and was intended to harmonize state law with the new federal scheduling architecture.⁵

The Prefatory Note to the Uniform Act emphasized uniformity:

“This Act is designed to achieve uniformity between the laws of the several States and those of the Federal Government.”⁶

Section 201 of the Uniform Act adopted scheduling criteria materially identical to 21 U.S.C. § 812(b)(1), including the requirement that a Schedule I substance have “no accepted medical use in treatment in the United States.”⁷

The drafters sought to:

1. Facilitate interstate enforcement cooperation;
2. Reduce inconsistent statutory definitions;
3. Harmonize evidentiary standards;
4. Preserve state sovereignty within a cooperative federal framework.⁸

Importantly, the Uniform Act standardized classification categories but did not mandate automatic federal conformity procedures.⁹

Thus, while the architecture of schedules became uniform, the mechanisms for responding to federal change were left to state design.

⸻

III. Three Structural Models of State Scheduling

Comparative analysis of state Controlled Substances Acts reveals three principal scheduling models.¹⁰

A. Automatic Conformity States

In automatic conformity states, federal schedule changes trigger automatic state adjustment unless the state authority objects within a defined window.¹¹

Typical language provides:

“If any substance is designated, rescheduled, or deleted as a controlled substance under federal law … the [state authority] shall similarly control the substance … unless within thirty days the authority objects.”¹²

These states operate as dynamic mirrors of federal scheduling.

⸻

B. Legislative-Retention States

Other states require affirmative legislative action to alter scheduling.¹³

South Dakota falls into this category.¹⁴ Its statutory structure provides:

“New legislation is required. The Department of Health makes recommendations to the Legislature to add, delete or reschedule a substance when the Department determines that the substance has a different potential for abuse.”¹⁵

At the same time, Schedule I criteria mirror federal definitional language. Section 34-20B-11 requires:

“(1) A high potential for abuse;
(2) No accepted medical use in treatment in the United States; and
(3) A lack of accepted safety for use under medical supervision.”¹⁶

South Dakota therefore incorporates federal definitional criteria while refusing automatic conformity.

This layered structure exemplifies the “static mirror” model described in WeedPress White Paper No. 1, where federal definitional language is embedded but conformity is not automatic.

⸻

C. Discretionary Conformity States

A third category grants administrative agencies discretion to adopt or reject federal changes through rulemaking procedures.¹⁷

These states require formal findings, notice, and hearing before altering schedules, often referencing federal evaluative factors.¹⁸

They reflect administrative federalism rather than legislative retention or automatic mirroring.

⸻

IV. The Eight-Factor Analytical Mirror

The federal CSA requires consideration of eight factors when determining scheduling.¹⁹ These include potential for abuse, scientific evidence, public health risk, and dependence liability.²⁰

Many states adopting the Uniform Act replicated or incorporated these analytic criteria.²¹

Thus, even when states diverge procedurally, they often retain federal methodology at the evaluative level.

Uniformity of logic persists even where conformity of outcome does not.

⸻

V. South Dakota’s Exemptions and Institutional Design

South Dakota’s statutory structure includes an exemption within its definition of marijuana for:

“a drug product approved by the United States Food and Drug Administration.”²²

This exemption appears at S.D. Codified Laws § 34-20B-1(12).²³

Thus, South Dakota simultaneously:

• Mirrors federal Schedule I definitional language;
• Recognizes FDA-approved drug products;
• Retains legislative supremacy over rescheduling.

This layered design reinforces that South Dakota embedded federal medical recognition mechanisms within definitional text, even while preserving legislative control over classification changes.

⸻

VI. Architectural Consequences After Federal Medical Recognition

If cannabis receives federal recognition as having “currently accepted medical use,”²⁴ consequences vary by structural model:

• Automatic states adjust unless objection occurs;
• Discretionary states must conduct rulemaking;
• Legislative-retention states require statutory amendment.

South Dakota remains in the third category.²⁵

Federal medical recognition would therefore not automatically alter its scheduling structure.

The issue becomes legislative coherence rather than administrative preemption.

⸻

VII. Conclusion: Uniform Categories, Divergent Mechanisms

The Uniform Controlled Substances Act harmonized scheduling categories nationwide.

It did not harmonize conformity mechanisms.

States chose:

• Dynamic mirror systems;
• Static legislative-retention systems;
• Administrative discretion models.

Those drafting decisions, made in the early 1970s, now determine how states respond to evolving federal medical determinations.

Drug law is administrative architecture.

And architecture governs response.

⸻

Footnotes

1. Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. No. 91-513, 84 Stat. 1236 (1970).
2. 21 U.S.C. § 812(b)(1).
3. Unif. Controlled Substances Act (Nat’l Conf. of Comm’rs on Unif. State Laws 1970).
4. Id.
5. Id. prefatory note.
6. Id.
7. Id. § 201.
8. Id. prefatory note.
9. Id. §§ 201–204.
10. Memorandum, State Controlled Substances Acts: Exemptions and Regulatory Mechanisms for Schedule Changes (Feb. 26, 2020) (on file with author).
11. Id.
12. Id.
13. Id.
14. Id.
15. S.D. Codified Laws § 34-20B-27.
16. S.D. Codified Laws § 34-20B-11.
17. Memorandum, supra note 10.
18. Id.
19. 21 U.S.C. § 811(c).
20. Id.
21. Unif. Controlled Substances Act § 201.
22. Memorandum, supra note 10.
23. S.D. Codified Laws § 34-20B-1(12) (exempting FDA-approved drug products from “marijuana” definition).
24. 21 U.S.C. § 812(b)(1).
25. Memorandum, supra note 10.

WeedPress Policy Series 

No. 1 — Legal Memorandum: Common Misconceptions in Cannabis Activism Regarding Federal Drug Law (January 25, 2026)

No. 2 — The Path to a Religious Cannabis Exemption: How Medical Cannabis Systems Change the RFRA Equation (January 27, 2026)

No. 3 — Structural Contradictions and Prospective Litigation Risk in Post-Rescheduling Cannabis Policy (February 6, 2026)

No. 4 — The Controlled Substances Act Is Not a Blunt Instrument — It Is an Architecture of Exceptions (February 13, 2026)

No. 5 — The Limits of § 822(d): What It Does — and Does Not — Authorize (February 13, 2026)

No. 6 — The Major Questions Doctrine and Cannabis Reform: Delegation, Scale, and Judicial Review (February 14, 2026)

No. 7 — Chevron’s Collapse and Cannabis Regulation: Judicial Review After Loper Bright (February 17, 2026)

No. 8 — Administrative Procedure Act Vulnerabilities in DEA Rescheduling(February 20, 2026)

No. 9 – No. 9 — Dormant Commerce Clause, Circuit Splits, and Cannabis Federalism (February 23, 2026)

No. 10 — Federal Preemption After Rescheduling: Conflict, Obstacle, and Cannabis Federalism (February 27, 2026)

No. 11 — Equal Protection and Economic Protectionism in Cannabis Licensing: Classification, Remedial Design, and Constitutional Limits (March 3, 2026)

No. 12 — Federal Rescheduling as a Preemption Trigger: Rational Basis, Conflict, and State Schedule I Exposure(March 6, 2026).

No. 13 — Criminal Prosecution After Federal Medical Recognition: Motions Practice, Rational Basis, and Schedule I Litigation Exposure (March 10, 2026).

Jason Karimi, Cannabis Federalism After Medical Recognition: Administrative Record, Rational Basis, and Vertical Separation of Powers, WeedPress White Paper No. 1 (Mar. 17, 2026).

No. 14 — The South Dakota Controlled Substances Act: Legislative Architecture, Intent, and Institutional Design in a Potential Federal Rescheduling Context(March 24, 2026).

No. 15 — The Uniform Controlled Substances Act and the Architecture of Modern Drug Scheduling: A Structural Analysis of State Scheduling Mechanisms in a Post-Medical Recognition Era (April 1, 2026).

About Weedpress Policy Series

The Weedpress Policy Series publishes in-depth, citation-supported analysis of federal cannabis law, regulatory policy, and enforcement practices. The series is designed to provide lawmakers, attorneys, journalists, and stakeholders with legally grounded, non-activist, non-promotional analysis focused on statutory reality and institutional accountability.

Weedpress Policy Series emphasizes:

• Federal statutory interpretation
• Congressional intent and legislative history
• Treaty and international law implications
• Administrative law and agency authority
• Oversight of enforcement discretion and regulatory gaps

Policy Series — Cannabis Federalism & Constitutional Structure

This article is part of the ongoing Policy Series examining federalism, administrative law, statutory interpretation, and constitutional structure in post-prohibition cannabis regulation. The Series evaluates institutional design, litigation exposure, and doctrinal development across federal and state systems.

Each installment is written as structural analysis rather than advocacy and is intended for legal, academic, and policy audiences